A study using a chemotherapeutic sensitivity assay and flow cytometry (FCM) to analyze the relationship between HIF-1 expression and sensitivity to chemotherapy revealed that HIF-1α inhibition reversed MDR in colon cancer cells via the downregulation of MDR1/P-gp [26]. Here, HIF1A is linked to malignant colon neoplasm.